- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Skymark Research Initiates Independent Research Coverage on Altair Nanotechnologies Inc.
Alberta | Posted on June 28th, 2010
Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Altair Nanotechnologies Inc. (ALTI 0.44, -0.03, -7.19%).
Skymark Research is currently offering a complimentary trial subscription. To view our research go to: www.skymarkresearch.com.
Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, www.skymarkresearch.com, for complete risks and disclosures.
About Skymark Research
Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.skymarkresearch.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.skymarkresearch.com/signup.php.
About Altair Nanotechnologies Inc.
Altair Nanotechnologies Inc. (ALTI 0.44, -0.03, -6.85%) is engaged in the business of developing, manufacturing and selling its nano lithium titanate battery products and providing related design, installation and test services.
For more information, please click here
Copyright © MarketwatchIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016